Reveal for T1D

Accelerated Type 1 diabetes (T1D) detection that meets you where you are

Proactive Care Powered by Precision Identification

85-90% of individuals with Type 1 diabetes are diagnosed at the most advanced stage1, when symptoms are severe and the risk of complications is highest. Current screening recommendations lack specificity for early detection, and most cases are missed until symptoms develop.

Reveal for T1D leverages advanced AI and existing EHR data to efficiently identify patients whose data suggests they would benefit from further testing for presymptomatic, early-stage Type 1 diabetes – enabling earlier diagnosis, and intervention when it matters most.

Proactive Care Powered by Precision Identification

85-90% of individuals with Type 1 diabetes are diagnosed at the most advanced stage1, when symptoms are severe and the risk of complications is highest. Current screening recommendations lack specificity for early detection, and most cases are missed until symptoms develop.

Reveal for T1D leverages advanced AI and existing EHR data to efficiently identify patients whose data suggests they would benefit from further testing for presymptomatic, early-stage Type 1 diabetes – enabling earlier diagnosis, and intervention when it matters most.

How Reveal for T1D Works

Reveal for T1D enables earlier detection without disruption, aligning with your existing clinical workflows to drive better outcomes.

Identify

AI analyzes existing patient data to surface those who may benefit from T1D antibody testing based on clinical patterns.

Engage

Provide patient education on the importance of early diagnosis for T1D and guidance toward confirmatory testing.

Accelerate

Support the efficient implementation of care pathways from early identification to clinical evaluation and intervention.

Impact

Support patients in receiving earlier intervention, which may help prevent life-threatening complications and improve long-term health.

47x improved screening efficiency

Smarter Screening, Greater Impact

Reveal for T1D helps top healthcare organizations maximize their current resources and clinical expertise, making early-stage detection routine and scalable.

Reveal for T1D Dashboard_Desktop

  • Amplify Existing Resources: Uncover more patients without additional FTEs or tiresome manual chart reviews.

  • Clinical Precision: Targets presymptomatic and early-stage T1D based on existing and readily clinically available data.

  • Operational Efficiency: Integrates natively with your existing clinical and patient engagement systems, enabling streamlined care pathways and measurable workflow gains.

  • Innovative Care: Be at the forefront of advancing Type 1 diabetes care, support internal research projects, and lead broader disease understanding.

  • Rapid Deployment: Deploy in weeks, not months, with standards-driven integration and enterprise-level security.

  • Financial & Clinical ROI: Accelerate value-based care metrics, reduce downstream complications, and generate new service line revenue from earlier intervention.

47x improved screening efficiency

Smarter Screening, Greater Impact

Reveal for T1D helps top healthcare organizations maximize their current resources and clinical expertise, making early-stage detection routine and scalable.

Reveal for T1D Dashboard_Desktop

  • Amplify Existing Resources: Uncover more patients without additional FTEs or tiresome manual chart reviews.

  • Clinical Precision: Targets presymptomatic and early-stage T1D based on existing and readily clinically available data.

  • Operational Efficiency: Integrates natively with your existing clinical and patient engagement systems, enabling streamlined care pathways and measurable workflow gains.

  • Innovative Care: Be at the forefront of advancing Type 1 diabetes care, support internal research projects, and lead broader disease understanding.

  • Rapid Deployment: Deploy in weeks, not months, with standards-driven integration and enterprise-level security.

  • Financial & Clinical ROI: Accelerate value-based care metrics, reduce downstream complications, and generate new service line revenue from earlier intervention.

Try Reveal for T1D at no-cost for up to a year

Try Reveal for T1D at no-cost for up to a year

The Urgency of Earlier Type 1 Diabetes Detection

Type 1 diabetes is an autoimmune disease where the immune system attacks insulin-producing beta cells in the pancreas, leading to life-long insulin dependence. The disease progresses through three distinct stages, all marked by changes in immune response and blood sugar control—early diagnosis and intervention can delay progression to insulin dependent, stage 3 diabetes and improve clinical outcomes.

Stage 1
Normal blood sugar

The body has started to develop antibodies against insulin-producing cells, but blood sugar is still normal and there are no symptoms.

Stage 2
Abnormal blood sugar

More insulin-producing cells are affected. Blood sugar levels begin to rise, though there are still no noticeable symptoms.

Stage 3
Clinical diagnosis

Most insulin-producing cells are lost. Blood sugar is high and diabetes symptoms such as increased thirst, urination, or weight loss are present.

Early diagnosis reduces life threatening diabetic ketoacidosis, improves lifetime glycemic control and clinical outcomes, and allows interventions to delay progression to Stage 3.

Delayed diagnosis results in significantly higher rates of diabetic ketoacidosis, poorer lifetime glycemic control and clinical outcomes, and medical trauma from acute diagnosis.

The Urgency of Earlier Type 1 Diabetes Detection

Type 1 diabetes is an autoimmune disease where the immune system attacks insulin-producing beta cells in the pancreas, leading to life-long insulin dependence. The disease progresses through three distinct stages, all marked by changes in immune response and blood sugar control—early diagnosis and intervention can delay progression to insulin dependent, stage 3 diabetes and improve clinical outcomes.

Stage 1
Normal blood sugar

The body has started to develop antibodies against insulin-producing cells, but blood sugar is still normal and there are no symptoms.

Stage 2
Abnormal blood sugar

More insulin-producing cells are affected. Blood sugar levels begin to rise, though there are still no noticeable symptoms.

Stage 3
Clinical diagnosis

Most insulin-producing cells are lost. Blood sugar is high and diabetes symptoms such as increased thirst, urination, or weight loss are present.

Featured Type 1 Diabetes Resources

Fact Sheet

Type 1 Diabetes Fact Sheet

Understand the basics behind Type 1 diabetes: what it is, how it progresses, and industry recommended screening approaches.

Reveal for T1D Main Header
Solution Overview

Reveal for T1D

A one page solution overview document that you can download and socialize to your team.

Early-stage-Type-1-Diabetes-identification-with-AI-min
Press Release

Lucem Health announces new initiative to accelerate early detection of Type 1 Diabetes (T1D)

Lucem Health launches Reveal for T1D, using AI and EHR data to identify early-stage T1D, backed by Sanofi to improve diagnosis and outcomes.

Read more

Early Detection Saves Lives

Bring the power of clinical AI to your organization today—so you can reveal hidden patient risks, focus your resources, and deliver higher clinical value, more proactive patient care.

Get In Touch